Holen Sie sich die Stockscreener-App
491.23
2.89%
-14.61
Vorhandelsmarkt:
492.53
1.30
+0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$505.84
Offen:
$499.6
24-Stunden-Volumen:
1.96M
Relative Volume:
1.51
Marktkapitalisierung:
$112.10B
Einnahmen:
$75.60B
Nettoeinkommen (Verlust:
$7.78B
KGV:
17.31
EPS:
28.3842
Netto-Cashflow:
$7.69B
1W Leistung:
+5.54%
1M Leistung:
+2.96%
6M Leistung:
+44.25%
1J Leistung:
+49.45%
1-Tages-Spanne:
$480.47
$500.93
1-Wochen-Bereich:
$461.85
$527.55
52-Wochen-Spanne:
$295.00
$527.55
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Vergleichen Sie HCA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
491.23 | 115.43B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
189.58 | 16.62B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.19 | 13.00B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
203.02 | 12.66B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
171.80 | 9.96B | 4.11B | 239.98M | 193.10M | 4.12 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
New York State Common Retirement Fund Cuts Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Stock Holdings Decreased by Truist Financial Corp - MarketBeat
Bank of New York Mellon Corp Sells 23,154 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare Aligns Nursing Leadership With $10b Buyback And Dividend Plan - Yahoo Finance
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds - TechStock²
Key facts: Analysts Raise HCA Healthcare Price Targets; Company Plans Cost Cuts - TradingView
Jefferies Financial Group Forecasts Strong Price Appreciation for HCA Healthcare (NYSE:HCA) Stock - MarketBeat
HCA Healthcare (HCA) Sees Increased Price Target by Jefferies | - GuruFocus
Hospital Operator HCA Healthcare Is Set For Solid Growth, Higher Value-Analyst - Benzinga
CEO Sam Hazen: HCA Healthcare is 'all in' on artificial intelligence - The Business Journals
RBC Capital Raises Price Target for HCA Healthcare to $555.00 | - GuruFocus
HCA Healthcare Inc (NYSE:HCA) Posts Mixed Result - FXDailyReport.Com
Royal Bank Of Canada Forecasts Strong Price Appreciation for HCA Healthcare (NYSE:HCA) Stock - MarketBeat
Jefferies Adjusts Price Target on HCA Healthcare Inc to $590 From $535, Maintains Buy Rating - marketscreener.com
Cantor Fitzgerald Adjusts Price Target on HCA Healthcare to $588 From $525, Maintains Overweight Rating - marketscreener.com
Cantor Fitzgerald Raises Price Target for HCA to $588 | HCA Stoc - GuruFocus
Oppenheimer Raises Price Target on HCA Healthcare to $540 From $500, Keeps Outperform Rating - marketscreener.com
Keybanc Maintains Overweight Rating for HCA, Raises Price Target to $550 | HCA Stock News - GuruFocus
KeyBanc raises HCA Healthcare stock price target to $550 on strong results - Investing.com
HCA Healthcare stock price target maintained at $503 by Bernstein - Investing.com
The Healthcare Titan: A 2026 Deep-Dive into HCA Healthcare (NYSE: HCA) - FinancialContent
Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for HCA Healthcare (NYSE:HCA) Stock - MarketBeat
Truist Financial Increases HCA Healthcare (NYSE:HCA) Price Target to $546.00 - MarketBeat
These Analysts Increase Their Forecasts On HCA Healthcare After Q4 Results - Benzinga
Barclays Raises HCA Price Target to $551, Maintains Overweight R - GuruFocus
HCA Healthcare (HCA) Sees Target Price Increase by Truist Securi - GuruFocus
HCA Healthcare (HCA): Deutsche Bank Raises Price Target Amid Buy Rating | HCA Stock News - GuruFocus
HCA Healthcare, Inc. (NYSE:HCA) Q4 2025 earnings call transcript - MSN
HCA Healthcare, Inc. (NYSE:HCA) Q4 2025 Earnings Call Transcript - Insider Monkey
HCA Healthcare's (NYSE:HCA) five-year earnings growth trails the solid shareholder returns - Yahoo Finance
Mutual of America Capital Management LLC Trims Position in HCA Healthcare, Inc. $HCA - MarketBeat
Goldman Sachs raises HCA Healthcare stock price target to $558 on strong results - Investing.com
HCA Healthcare Q4 2025 Earnings & 2026 Outlook | Financial ResultsNews and Statistics - IndexBox
HCA Healthcare (NYSE:HCA) Reaches New 12-Month High on Better-Than-Expected Earnings - MarketBeat
Encompass Health or HCA Healthcare: Which Stock Has More Upside? - Trefis
HCA Q4 Deep Dive: Cost Discipline, Outpatient Investments, and Policy Headwinds Define Outlook - TradingView
Why Is HCA Healthcare (HCA) Stock Soaring Today - The Globe and Mail
This Week's Healthcare Earnings: UnitedHealth, HCA, J&J - Law360
HCA Healthcare (NYSE:HCA) Misses Q4 CY2025 Revenue Estimates - The Globe and Mail
HCA Healthcare jumps after Q4 profit beat, issues upbeat 2026 outlook and boosts shareholder returns - AlphaStreet
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA Healthcare Inc (HCA) Q4 2025 Earnings Call Highlights: Robus - GuruFocus
HCA Healthcare, Inc. (NYSE:HCA) Declares Quarterly Dividend of $0.78 - MarketBeat
HCA Healthcare Inc (HCA) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - Yahoo Finance
HCA expects $1 billion hit from loss of ACA tax credits, Medicaid changes - statnews.com
HCA shares soar on Q4 numbers that beat Wall Street estimates - nashvillepost.com
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes - sharewise.com
HCA To Tap Resiliency and Repurchase Program To Keep Profit Growth Momentum - Morningstar
HCA Healthcare Q4 Earnings Call Highlights - MarketBeat
HCA bullish on outpatient expansion amid economic headwinds - Modern Healthcare
HCA Healthcare’s Shares on the Rise: Price Target Upgrades and Leadership Changes Signal Growth - StocksToTrade
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):